Bladder cancer: open trials in Norway

12 open trials have a site in Norway. Registry data; only the trial team decides who can take part.

NCT05614739
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Trial Treatment · Phase 1 · Eli Lilly and Company
Haukeland University Hospital, Bergen · Oslo University Hospital, Oslo
Registry updated 2026-11-04
2024-516906-47-00
Dato-DXd plus Carboplatin or Cisplatin versus Gemcitabine plus Carboplatin or Cisplatin in Previously Treated la/mUC.
Trial Treatment · Phase 2/3 · Daiichi Sankyo Inc.
Akershus University Hospital, Loerenskog · Helse Stavanger HF, Stavanger · Sykehuset I Vestfold HF, Toensberg
Registry updated 2026-10-29
NCT07144319
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy
Research · Photocure
Oslo University Hospital, Oslo
Registry updated 2026-10-29
NCT07222488
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Akershus University Hospital, Loerenskog
Registry updated 2026-10-29
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Akershus universitetssykehus, Lørenskog · Haukeland universitetssjukehus, Lørenskog · Oslo Universitetssykehus HF, Radiumhospitalet, Oslo
Registry updated 2026-10-26
NCT02969083
Feasibility study of Neo-adjuvant (before surgery) versus Adjuvant (after surgery) chemotherapy in Upper Tract Urothelial Carcinoma
Trial Treatment · Phase 2 · European Uro-Oncology Group Stichting
University In Bergen, Bergen
Registry updated 2026-10-05
NCT07106762
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Trial Treatment · Phase 2/3 · Bristol-Myers Squibb
Akershus universitetssykehus, Lørenskog · Sykehuset Østfold Kalnes, Sarpsborg · Sykehuset i Vestfold, Tønsberg
Registry updated 2026-07-29
NCT05503797
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Trial Treatment · Phase 2 · Fore Biotherapeutics
Helse Bergen HF, Bergen · Oslo University Hospital HF, Oslo
Registry updated 2026-07-27
NCT07602010
Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging
Research · Oslo University Hospital
Oslo University Hospital, Oslo
Registry updated 2026-05-22
2022-502221-18-00
Chemoablation or bladder resection with adjuvant chemotherapy in recurrent non-muscle invasive bladder cancer
Trial Treatment · Phase 4 · Aarhus University
Helse Bergen HF, Bergen · Sykehuset I Vestfold HF, Toensberg
Registry updated 2026-04-13
NCT07077447
The Danish Bladder Cancer Group 23 Study - A European Study on Cancer in the Upper Urinary Tract
Research · Zealand University Hospital
Haukeland University Hospital, Bergen
Registry updated 2025-12-22
NCT06781879
Chemoablation Or Bladder Resection With Adjuvant Chemotherapy in Recurrent Non-Muscle Invasive Bladder Cancer
Trial Treatment · Phase 4 · Jakob Kristian Jakobsen
Haukeland University Hospital, Bergen · Vestfold Hospital Trust, Tønsberg
Registry updated 2025-10-03

All Bladder cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error